RA CAPITAL MANAGEMENT
RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. Their team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and board levels. They invest in companies with promising technologies and products. Their approach is to achieve a superior understanding of data, experimental/trial design, regulatory process, and commercial potential. When appropriate, they can offer their portfolio companies leads on in-licensing opportunities and strategic partnerships, as well as insight into the demands of the public markets.
RA CAPITAL MANAGEMENT
Industry:
Biotechnology Finance Financial Services Life Science Medical
Founded:
2001-01-01
Status:
Active
Contact:
617.778.2500
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag
Similar Organizations
Aditum Bio
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets.
AGC Partners
AGC Partners is a global tech-focused investment bank and leading SaaS advisor.
Alliance Life Sciences
Alliance Life Sciences is a leading management & technology consultancy for pharma manufacturers & Life Sciences firms.
Back Bay Life Science Advisors
Back Bay Life Science Advisors provides strategy consulting and transaction advisory services to the life science industry.
Five Points Capital
Five Points Capital is a leading private equity manager, exclusively focused on the U.S. lower middle market.
Beach Point Capital Management
Beach Point Capital Management is a multi-billion dollar investment manager.
Beyond Next Ventures
Beyond Next Ventures is a Tokyo-based venture capital firm that invests in medical and life science fields.
BlueSky Capital
BlueSky Capital is an Ontario-based investment firm focused on software, financial services, biomedical, and energy opportunities.
Bodhi Tree Asset Management
Bodhi Tree Asset Management is an investment advisor that uses evidence-based approaches to create a high-quality stock portfolio.
Breakout Labs
Breakout Labs support a portfolio of early-stage companies in areas ranging from food science and biomedicine to clean energy.
Chione
Chione is an investment company that aims to finance companies in the biomedical sector.
Chiron Ventures
Chiron Ventures is an investment firm specializes in innovation and investment in medical health.
Deep Track Capital
Deep Track Capital is an investment firm focused exclusively on the life sciences industry.
East West Capital Limited
Investment management specialists with a life sciences and emerging technologies focus
First Affirmative Financial Network
First Affirmative Financial Network is a registered investment advisor specializing in sustainable, responsible, Impact (SRI) investing.
FreeMind
FreeMind Group is an consulting firm.
Greenfire Bio
Greenfire Bio operates as a life science development and investment company.
Hadean Ventures
Hadean is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region.
Haemalogix
Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.
Innova Memphis
Innova Memphis invests in early stage businesses related to biosciences, healthcare, technology, and AgTech.
Kerogen Capital
Kerogen Capital is an independent private equity fund manager specialising in the international oil and gas sector.
Lombard Investments
Lombard is a leading international private equity investment manager with offices in Bangkok, Hong Kong and San Francisco, and extensive
LYFE Capital
LYFE Capital is a life science investment firm.
Mass Medical Angels
Mass Medical Angels is dedicated to providing funding and mentoring services the companies in the healthcare and life sciences sector.
Omninet Capital
Omninet Capital has been at the forefront of real estate investing and venture capital for more than 20 years.
Glouston Capital Partners
Glouston Capital Partners is a private equity investment specialist with over 20 years of dedicated experience.
Progression Capital Africa
Progression Capital Africa is a manager of private equity fund specializing in financial services financial technology and adjacent sectors.
R42 Group
R42 Group actively invents and finances deep science ventures.
Sahsen Ventures
Sahsen Ventures makes investments in for-profit and nonprofit organizations with an emphasis on technology and biotechnology.
Sands Capital Ventures
Sands Capital is an investment manager who seeks to invest in technology and life sciences businesses from Series A through public listing..
Scion Asset Management
Scion Asset Management®, LLC is a private investment firm founded and led by Dr. Michael J. Burry.
Smart Agro
Smart Agro specializes in investing and improving companies in the agro-tech fields.
Steinberg Valentino Group
Steinberg Valentino specialize in investor relations and business advisory services.
Third Point Ventures
Third Point Ventures is an investment firm that focuses on enterprise, fintech, mobile, and healthcare innovation.
TT International
TT International is a high alpha specialist, offering a range of long only and hedge fund strategies.
Vantage Capital
Vantage Capital commenced business in 2001 as a black owned and managed private equity fund manager.
Velocity Capital Management
Velocity Capital Management is the Investment Advisor to the Velocity Technology and Communications Fund, an offshore Delaware Business.
Xerys
Xery is a portfolio management Company specializing in Venture Capital - Biotech, Medtech, Cleantech, Technology
Yonjin Venture
Yonjin Venture is an investment firm specializing in investing in early and mid-stage life science companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-26 | Carmot Therapeutics | RA Capital Management investment in Series D - Carmot Therapeutics | 160 M USD |
| 2022-07-20 | MMI | RA Capital Management investment in Series B - MMI | 75 M USD |
| 2022-07-12 | Napigen | RA Capital Management investment in Seed Round - Napigen | 7.85 M USD |
| 2022-06-28 | Cerebral Therapeutics | RA Capital Management investment in Series C - Cerebral Therapeutics | 40 M USD |
| 2022-06-09 | DBV Technologies | RA Capital Management investment in Post-IPO Equity - DBV Technologies | 181 M EUR |
| 2022-06-08 | Mineralys Therapeutics | RA Capital Management investment in Series B - Mineralys Therapeutics | 118 M USD |
| 2022-06-01 | Concert Pharmaceuticals | RA Capital Management investment in Post-IPO Equity - Concert Pharmaceuticals | 66.4 M USD |
| 2022-05-16 | Celcuity | RA Capital Management investment in Post-IPO Equity - Celcuity | 100 M USD |
| 2022-04-19 | Sionna Therapeutics | RA Capital Management investment in Series B - Sionna Therapeutics | 110 M USD |
| 2022-04-14 | Be Biopharma | RA Capital Management investment in Series B - Be Biopharma | 130 M USD |